The acquisition of San Diego-based ValueGene expands IDT's presence in Southern California.
The companies will combine their respective technologies and expertise to develop new products for low-input, targeted RNA-seq applications.
As the interference proceeding to resolve claims in foundational CRISPR patents draws near, Caribou has given IDT worldwide rights to sell RUO reagents.
The partnership will pair Sophia's informatics infrastructure with IDT's panel to provide an NGS-based solution for routine clinical diagnostics.
IDT said that the acquisition is expected to expand the customer base for its custom synthetic nucleic acid business across Southeast Asia.
The new 8,000-square-foot building will support oligonucleotide manufacturing for molecular biology applications such as qPCR, next-generation sequencing, and synthetic biology.
The company'sSan Diegomanufacturing site received ISO 14001:2004 certification, making both of its facilities ISO 14001-certified.
The firms intend to seek Emergency Use Authorization from the US Food and Drug Administration once the Ebola assay is developed.
NEW YORK (GenomeWeb) – Integrated DNA Technologies said today it has obtained a license to manufacture and supply EliTech Group's MGB Eclipse qPCR probes for use in human in vitro diagnostic tests.
NEW YORK (GenomeWeb) – Transgenomic today announced an agreement to sell the rights to it Surveyor Nuclease technology and assets to Integrated DNA Technologies for a minimum of $4.25 million.
In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.
Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.
According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.
National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.